A non-interventional study to examine patient characteristics and drug utilization patterns in migraine patients treated with prophylactic drugs in Nordic countries

First published 29/07/2020

Last updated 12/06/2025

EU PAS number:

EUPAS36014

Study

Finalised

Documents

Study protocol

Initial protocol

CAMG334A2023-v02-Redacted-Protocol

English (1002.23 KB - PDF)View document

Study results

Study report

camg334a2023--legacy-clinical-study-report_Redacted.pdf

English (1.73 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs